Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05868239 · ClinicalTrials.gov registry record · NA

Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study

A NA study of COVID-19 and Cardiac Arrest, sponsored by KidSIM Simulation Program.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
4
Study locations

NCT05868239 is a NA study of COVID-19 and Cardiac Arrest that is actively recruiting participants, run by KidSIM Simulation Program. The registered enrollment target is 240 participants, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05868239, a NA study of COVID-19 and Cardiac Arrest, is actively recruiting participants, sponsored by KidSIM Simulation Program.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
4
Study locations

Study Summary

Aerosol Generating Medical Procedures (AGMP) are procedures that have the potential to create tiny particles suspended in the air. These particles can contain germs such as viruses. The Coronavirus Disease 2019 (COVID-19) pandemic was caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients infected with SARS-CoV-2 experience unusually high rates of critical illness that needs advanced airway management and intensive care unit admission. Bag-valve-mask (BVM) ventilation, endotracheal Intubation (ETI) and chest compressions are sometimes required for critically ill COVID-19 patients, and may contribute to a high risk of infection amongst Health Care Workers (HCW). To lessen HCW risk during high-risk procedures, a device called an aerosol box has been developed to place over the head of the patient, shielding the provider's face from virus droplets suspended in the air. The purpose of this research study is to better understand how particles disperse during AGMPs, more specifically during the provision of cardiopulmonary resuscitation (CPR). The project team hopes what is learned from the project can help inform infection control measures. This could help make changes to the clinical environment and make it safer for HCW's. The investigators intend to explore how an aerosol box performs in reducing contamination of HCW's who perform critical airway interventions during resuscitation events.

Interventions

  • DEVICE Aerosol box

Study Locations (4)

California

  • Department of Emergency Medicine, Children's Hospital of Los Angeles - Los Angeles

Alberta

  • KidSIM, Alberta Children's Hospital - Calgary

Ontario

  • Department of Pediatrics, The Hospital for Sick Children - Toronto

Quebec

  • Department of Pediatrics, CHU Sainte-Justine - Montreal

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2023-09-01
Est. Completion 2026-12-01
Phase NA

Sponsor

KidSIM Simulation Program

3 total trials

What the Registry Record Tells You About NCT05868239

The ClinicalTrials.gov registry entry for NCT05868239 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is KidSIM Simulation Program, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Aerosol box is the first listed.

NCT05868239 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Alberta, Ontario.

Frequently Asked Questions

What is clinical trial NCT05868239 about?

NCT05868239 is a clinical study titled "Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study". Aerosol Generating Medical Procedures (AGMP) are procedures that have the potential to create tiny particles suspended in the air. These particles can contain germs such as viruses. The Coronavirus Disease 2019 (COVID-19) pandemic was caused by the novel severe acute respiratory syndrome coronavirus...

What is the current status of trial NCT05868239?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-09-01. Estimated completion is 2026-12-01.

What conditions does trial NCT05868239 study?

This clinical trial studies the following conditions: COVID-19, Cardiac Arrest, Coronavirus.

What interventions are being tested in trial NCT05868239?

The interventions under investigation include: Aerosol box (DEVICE).

Who is sponsoring clinical trial NCT05868239?

This trial is sponsored by KidSIM Simulation Program, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05868239 being conducted?

This trial has 4 study locations across California, Alberta, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.